Bio-Rad unveils several new molecular quality controls, among which is the first molecular control to be issued a de novo clearance from the FDA. Join Max Williams, Global Marketing Director, Bio-Rad, Rochelle Stahl, Product Manager, Molecular Diagnostic Controls, Bio-Rad and Jamie Platt, PhD, CGMBS, MB(ASCP), President and Founder of BRIDGenomics to learn about how these new controls conveniently monitor the analytical process including sample extraction, amplification and detection. An exciting new video will be debuted highlighting Bio-Rad’s new offerings for molecular diagnostics testing. Light refreshments will be served.
Check out this Video:
https://www.youtube.com/watch?v=RJ-BT1J1Gt8&feature=youtu.be
